Giacomini receives 2023 Reynold Spector Award in Clinical Pharmacology and Translational Medicine

In honor of her “pioneering work on membrane transporters and her exceptional leadership in the field of clinical pharmacology,” Kathy Giacomini, PhD, BSPharm, received the 2023 Reynold Spector Award in Clinical Pharmacology and Translational Medicine from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

ASPET is one of the world’s leading organizations of clinical pharmacologists, aiming to promote the growth of pharmacological research.

Giacomini, dean of the UCSF School of Pharmacy and faculty member in the Department of Bioengineering and Therapeutic Sciences, was particularly touched to receive an award named after Reynold Spector, MD, a clinical pharmacologist whose influential career spanned academia and industry.

“It’s very exciting, as Reynold Spector was one of my heroes as a young faculty member,” said Giacomini. “I’ve been lucky to take inspiration from ASPET and the broader scientific community for many years, and I look forward to seeing how the next generation of pharmacologists build on this ongoing legacy.”

The award will be presented to Giacomini on May 21, 2023, during the ASPET 2023 Annual Meeting in St. Louis. She will also present a lecture on her work, titled “Unlocking the Biological and Pharmacological Roles of Drug Transporters,” as part of ASPET’s new online VIP Award Lecture Series in conjunction with the annual meeting.